Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1518-2014Class II

IMMULITE 2000 /IMMULITE 2000 XPi Systems TIE Total IgE, REF L2KIE2, SMN 10380873, and L2KIE6, SMN 10380872...

Siemens Healthcare Diagnostics Inc. / initiated 2013-12-20 / Terminated

Siemens Healthcare Diagnostics began a recall of IMMULITE 2000 /IMMULITE 2000 XPi Systems TIE Total IgE, REF L2KIE2, SMN 10380873, and L2KIE6, SMN 10380872, IVD --- Siemens Healthcare Diagnostics Products... on . FDA classified it as Class II and gives the reason as "Siemens confirmed an overall average positive bias of 23% against the WHO 2nd IRP 75/502 with the IMMULITE Systems Total IgE assays". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1518-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
IMMULITE 2000 /IMMULITE 2000 XPi Systems TIE Total IgE, REF L2KIE2, SMN 10380873, and L2KIE6, SMN 10380872, IVD --- Siemens Healthcare Diagnostics Products Ltd. For in vitro diagnostic use with the IMMULITE, IMMULITE 1000, and IMMULITE 2000/ IMMULITE 2000 XPi Systems Analyzers - for the quantitative measurement of Total Immunoglobulin type E (IgE) in serum.
Product code
JHR Radioimmunoassay, Immunoglobulins (D, E)
Reason for recall
Siemens confirmed an overall average positive bias of 23% against the WHO 2nd IRP 75/502 with the IMMULITE Systems Total IgE assays.
FDA root cause
Under Investigation by firm
Action
Urgent Medical Device Correction Letters (dated 12/20/13) and effectiveness check response forms were sent to customers on 12/20/13 via FedEx to inform them of the issue. Customers were requested to complete and return the Effectiveness Check questionnaire attached to the Urgent Medical Device Correction letter within thirty (30) days. Field service personnel were sent a support document describing the issue and instructing them how to deal with customer questions.
Quantity in commerce
18,489 units
Distribution
Worldwide distribution.
Product codes and lots
Lots 260 through 275

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1518-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1517-2014Class IITerminatedVoluntary: Firm initiated
Z-1518-2014Class IITerminatedVoluntary: Firm initiated